Altamira Gold Corp. Reports Trench Results of 6m @ 21.74g/t Gold at the New Baldo East Zone, Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") is pleased to provide additional results from the ongoing drill...Read More
60 volunteers to be enrolled Data expected in the first quarter of 2018GAITHERSBURG, Md., Aug.21, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the Company has submitted an Investigational New Drug (IND) application to the U.S...Read More
GAITHERSBURG, Md., Aug.21, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced it has closed its offering of approximately 15,656 shares of Series B convertible preferred stock and warrants. The Company received approximately $13.0...Read More
GAITHERSBURG, Md., Aug.17, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced it has entered into a definitive securities purchase agreement with new and existing investors to sell an aggregate of 15,656 shares of Series B convertib...Read More
Completed merger with PharmAthene, began trading on NASDAQ as Altimmune, Inc. (ALT) Remains on track to initiate Phase 2 trial in NasoVAX in Third QuarterHepTcell Phase 1 clinical trial ongoing in the UK and South Korea, top-line data expected in Fourth QuarterConference call and webcast at 8:30...Read More
Altamira Gold Corp. Identifies Two New Mineralized Zones at Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") is pleased to announce that it has identified two new previously unrecognized mineralized zones i...Read More
GAITHERSBURG, Md., July31, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that it will report financial results for the three and six months ended June 30, 2017 before the market open, and host a conference call at 8:30am Easter...Read More
Altamira Gold Corp. Announces Completion of Debt Settlement, Issues Options. Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), formerly Equitas Resources Corp. ("Altamira" or the "Company") is pleased to announce that it the TSX Venture Exchange has accepted for...Read More
ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the year ended December 31, 2016. Fourth quarter and subsequent operational highlight...Read More
(TheNewswire) Toronto, ON / TheNewswire / April 21, 2017 - At the request of IIROC, Alturas Minerals Corp. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Alturas Mine...Read More
GAITHERSBURG, Md., May04, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the combined company was renamed Altimmune, Inc., and will commence trading on The NASDAQ C...Read More
GAITHERSBURG, Md., May16, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.Dr. Tasker joined the company in April 2016 as Senior Vice Presid...Read More
GAITHERSBURG, Md., June19, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the BIO International Convention, taking place...Read More
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2017) - Trading resumes in: Company: Altamira Gold Corp. TSX-V Symbol: ALTA Resumption Time (ET): 08:00 April 18,2017 IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed...Read More
VANCOUVER, April 17, 2017 /CNW/ - Trading resumes in: Company: ALTAMIRA GOLD CORP., Formerly Equitas Resources Corp. ("EQT") TSX-Venture Symbol: ALTA Resumption (ET): Tuesday April 18/17- 08:00 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security o...Read More
Altamira Gold Corp. Announces Commencement of Trenching Program at Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), formerly Equitas Resources Corp. ("Altamira" or the "Company") is pleased to announce that it has commenced a program of...Read More
Altamira Gold Corp. announces commencement of drill program at Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), formerly Equitas Resources Corp. ("Altamira" or the "Company") is pleased to announce that it has commenced the planned prog...Read More